Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Esperion Therapeutics, Inc. (ESPR)

« Back to company index

ESPR Chatter Timeline

Stock Ticker for ESPR

Most Active Tweeters for ESPR

UserTweets
@Tickeron 14
@gcassidy718 7
@BlueBioNow 6
@glareone 5
@WeekHerald 4

Recent Tweets for ESPR

Tickeron @Tickeron
$ESPR's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/udGE0LOaUP
July 3rd 2020, 7:07pm
WeekHerald @WeekHerald
Esperion Therapeutics $ESPR Now Covered by Analysts at Credit Suisse Group https://t.co/rkrviAaHzA
July 3rd 2020, 2:07am
Tickeron @Tickeron
$ESPR's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/3QRfwkkAoE
July 2nd 2020, 5:07pm
ninedee21 @ninedee21
RT @ZolmaxNews: Brokerages Expect Esperion Therapeutics Inc $ESPR Will Post Earnings of $1.92 Per Share https://t.co/yamIP2zu60
July 2nd 2020, 4:07am
ZolmaxNews @ZolmaxNews
Brokerages Expect Esperion Therapeutics Inc $ESPR Will Post Earnings of $1.92 Per Share https://t.co/yamIP2zu60
July 2nd 2020, 4:07am
Tickeron @Tickeron
$ESPR in +11.79% Uptrend, rising for three consecutive days on June 30, 2020. View odds for this and other indicato… https://t.co/v78KXxxL6J
July 1st 2020, 5:07pm
AlertTrade @AlertTrade
RT @Briefingcom: $ESPR: Esperion Therapeutics announces publication of pooled efficacy analysis from Phase 3 studies of NEXLETOL https://t.…
July 1st 2020, 1:07pm
Briefingcom @Briefingcom
$ESPR: Esperion Therapeutics announces publication of pooled efficacy analysis from Phase 3 studies of NEXLETOL https://t.co/a7xTFEpr2m
July 1st 2020, 1:07pm
otcdynamics @otcdynamics
$ESPR Esperion Announces Publication in the Journal of the American Medical Association Cardiology of Pooled https://t.co/NssxZpcmre
July 1st 2020, 11:07am
BWcapital_ @BWcapital_
$ESPR: Esperion Announces Publication in the Journal of the American Medical Association Cardiology of Pooled Effic… https://t.co/OY9ZCEGB8z
July 1st 2020, 11:07am
stock_titan @stock_titan
$ESPR Esperion Announces Publication in the Journal of the American Medical Association Cardiology of Pooled Effica… https://t.co/YCbPuv7Gsp
July 1st 2020, 11:07am
Tickeron @Tickeron
$ESPR enters an Uptrend because Momentum Indicator exceeded the 0 level on June 25, 2020. View odds for this and ot… https://t.co/xjxzBtTGjf
June 30th 2020, 10:06pm
LukeTheInvestor @LukeTheInvestor
$ESPR with a ??? day. First price target $55. https://t.co/l3p2FnIyWI
June 30th 2020, 7:06pm
BobMonopoli @BobMonopoli
RT @glareone: $ESPR Updated daily chart with new target! Lets see https://t.co/cOfcE5OhFC https://t.co/WvfSoQaBK5
June 30th 2020, 2:06pm
glareone @glareone
$ESPR Updated daily chart with new target! Lets see https://t.co/cOfcE5OhFC https://t.co/WvfSoQaBK5
June 30th 2020, 2:06pm
glareone @glareone
Thank you! Go $ESPR https://t.co/2JqzEs1Kx2
June 30th 2020, 11:06am
biopadawan @biopadawan
RT @haodongvli: $ESPR product launch to watch!
June 30th 2020, 11:06am
BobMonopoli @BobMonopoli
$ESPR ... Boom! https://t.co/v39eNMz6ZA
June 30th 2020, 11:06am
haodongvli @haodongvli
$ESPR product launch to watch!
June 30th 2020, 11:06am
WatchlistN @WatchlistN
Esperion Therapeutics $ESPR Receives New Coverage from Analysts at Credit Suisse Group https://t.co/abNGuO1ssY
June 30th 2020, 4:06am
ThisLincolnian @ThisLincolnian
Esperion Therapeutics $ESPR Receives New Coverage from Analysts at Credit Suisse Group https://t.co/9GWoXWZi9B
June 30th 2020, 4:06am
ConsumerFeed @ConsumerFeed
Esperion Therapeutics $ESPR Receives New Coverage from Analysts at Credit Suisse Group https://t.co/fHAWY5gfIZ
June 30th 2020, 4:06am
ZolmaxNews @ZolmaxNews
Esperion Therapeutics $ESPR Research Coverage Started at Credit Suisse Group https://t.co/XkwB8quACK
June 30th 2020, 3:06am
EnterpriseLeade @EnterpriseLeade
Esperion Therapeutics $ESPR Research Coverage Started at Credit Suisse Group https://t.co/YJDAzohtfu
June 30th 2020, 3:06am
WeekHerald @WeekHerald
Esperion Therapeutics $ESPR Receives “Buy” Rating from Stifel Nicolaus https://t.co/UdD0ujcbl8
June 30th 2020, 2:06am
gcassidy718 @gcassidy718
$ESPR definitely going to finish over $51.91 2.81 % change recently https://t.co/ZJ7rwkXcgV
June 29th 2020, 10:06pm
Tickeron @Tickeron
$ESPR in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on June 8, 2020. View odds fo… https://t.co/DDpTAU9AaH
June 29th 2020, 7:06pm
gcassidy718 @gcassidy718
$ESPR major movements -2.28 % change recently https://t.co/ZJ7rwkXcgV
June 29th 2020, 6:06pm
rmacmillan310 @rmacmillan310
$ESPR I'd like to make an exit, just not now -2.28 % change recently https://t.co/QKYeozZct6
June 29th 2020, 6:06pm
ConsumerFeed @ConsumerFeed
Stifel Nicolaus Reaffirms “Buy” Rating for Esperion Therapeutics $ESPR https://t.co/Mk4fEIFZke
June 29th 2020, 1:06am
stocknewstimes @stocknewstimes
Stifel Nicolaus Reaffirms “Buy” Rating for Esperion Therapeutics $ESPR https://t.co/1oimD7r3WM
June 29th 2020, 1:06am
BlueBioNow @BlueBioNow
$ESPR damn if we pass $41.31 -2.28 % change recently https://t.co/ZFif3yGLgm
June 28th 2020, 6:06pm
Tickeron @Tickeron
$ESPR enters an Uptrend because Momentum Indicator exceeded the 0 level on June 25, 2020. View odds for this and ot… https://t.co/4MonNlKOzj
June 28th 2020, 5:06pm
BlueBioNow @BlueBioNow
$ESPR buyer at $50.49 -2.28 % change recently https://t.co/ZFif3yGLgm
June 28th 2020, 10:06am
Gambiste1 @Gambiste1
RT @bret_jensen: $ESPR - The Play On Esperion Therapeutics. https://t.co/Bp8YejBdLO
June 28th 2020, 7:06am
EnterpriseLeade @EnterpriseLeade
Stifel Nicolaus Reiterates Buy Rating for Esperion Therapeutics $ESPR https://t.co/UiKMdIjYIW
June 28th 2020, 5:06am
ThisLincolnian @ThisLincolnian
Esperion Therapeutics’ $ESPR Buy Rating Reiterated at Stifel Nicolaus https://t.co/SIjLXjCj1f
June 28th 2020, 5:06am
dakotafinancial @dakotafinancial
Stifel Nicolaus Reiterates Buy Rating for Esperion Therapeutics $ESPR https://t.co/OpPWkl3PXd
June 28th 2020, 5:06am
BlueBioNow @BlueBioNow
$ESPR Stock is under performing. . . -2.28 % change recently https://t.co/ZFif3yGLgm
June 27th 2020, 9:06pm
rmacmillan310 @rmacmillan310
Instinct is telling me $ESPR is going down to $41.31. https://t.co/QKYeozZct6
June 27th 2020, 6:06pm
Tickeron @Tickeron
$ESPR enters an Uptrend as Momentum Indicator exceeded the 0 level on June 25, 2020. View odds for this and other i… https://t.co/TVcmfpz3Wp
June 27th 2020, 6:06pm
OlympiaReport @OlympiaReport
Esperion Therapeutics $ESPR Given “Buy” Rating at Stifel Nicolaus https://t.co/8HbowrsWMv
June 27th 2020, 9:06am
AmericanBanking @AmericanBanking
Esperion Therapeutics’ $ESPR Buy Rating Reiterated at Stifel Nicolaus https://t.co/lB21btC2xy #stocks
June 27th 2020, 6:06am
ZolmaxNews @ZolmaxNews
Esperion Therapeutics $ESPR Receives “Buy” Rating from Stifel Nicolaus https://t.co/OlqddTdfzY
June 27th 2020, 4:06am
TickerReport @TickerReport
Esperion Therapeutics $ESPR Rating Reiterated by Stifel Nicolaus https://t.co/DSvz6Z5L9p
June 27th 2020, 4:06am
TheMarketsDaily @TheMarketsDaily
Esperion Therapeutics $ESPR Rating Reiterated by Stifel Nicolaus https://t.co/z06TfZtOob
June 27th 2020, 4:06am
dailypoliticaln @dailypoliticaln
Esperion Therapeutics $ESPR Rating Reiterated by Stifel Nicolaus https://t.co/2lyluU1ehz
June 27th 2020, 4:06am
WeekHerald @WeekHerald
Esperion Therapeutics $ESPR Receives New Coverage from Analysts at Northland Securities https://t.co/rs4McfNDFy
June 27th 2020, 3:06am
HealthcareBeat @HealthcareBeat
Q2 2020 Earnings Estimate for Esperion Therapeutics Inc Issued By Jefferies Financial Group $ESPR https://t.co/FPMf2nIdIE
June 27th 2020, 2:06am
dispatchtribune @dispatchtribune
Q2 2020 Earnings Estimate for Esperion Therapeutics Inc $ESPR Issued By Jefferies Financial Group https://t.co/dfLMkXTfmT
June 27th 2020, 1:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.